Percutaneous cryoablation as a salvage therapy for local recurrence of lung cancer

Taichiro Goto, Yotaro Izumi, Seishi Nakatsuka, Hiroaki Nomori

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A 66-year-old male was diagnosed with inoperable non-small cell lung cancer, and underwent chemoradiotherapy, to which he achieved a partial response. During subsequent follow-up, positron emission tomography showed a fluorodeoxyglucose uptake lesion within the primary tumor, without evidence of metastatic foci elsewhere in the body. As local disease progression was most suspected, cryoablation was performed for the lesion with high fluorodeoxyglucose uptake. After treatment, there has been no evidence of recurrence for 12 months. Herein, we present a case of percutaneous cryoablation as a salvage therapy for recurrent lung cancer after chemoradiotherapy.

Original languageEnglish
JournalAnnals of Thoracic Surgery
Volume94
Issue number2
DOIs
Publication statusPublished - 2012 Aug

Fingerprint

Salvage Therapy
Cryosurgery
Chemoradiotherapy
Lung Neoplasms
Recurrence
Non-Small Cell Lung Carcinoma
Positron-Emission Tomography
Disease Progression
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Percutaneous cryoablation as a salvage therapy for local recurrence of lung cancer. / Goto, Taichiro; Izumi, Yotaro; Nakatsuka, Seishi; Nomori, Hiroaki.

In: Annals of Thoracic Surgery, Vol. 94, No. 2, 08.2012.

Research output: Contribution to journalArticle

@article{74d79e3c647f46478d18c3ddd5d330f7,
title = "Percutaneous cryoablation as a salvage therapy for local recurrence of lung cancer",
abstract = "A 66-year-old male was diagnosed with inoperable non-small cell lung cancer, and underwent chemoradiotherapy, to which he achieved a partial response. During subsequent follow-up, positron emission tomography showed a fluorodeoxyglucose uptake lesion within the primary tumor, without evidence of metastatic foci elsewhere in the body. As local disease progression was most suspected, cryoablation was performed for the lesion with high fluorodeoxyglucose uptake. After treatment, there has been no evidence of recurrence for 12 months. Herein, we present a case of percutaneous cryoablation as a salvage therapy for recurrent lung cancer after chemoradiotherapy.",
author = "Taichiro Goto and Yotaro Izumi and Seishi Nakatsuka and Hiroaki Nomori",
year = "2012",
month = "8",
doi = "10.1016/j.athoracsur.2012.01.090",
language = "English",
volume = "94",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Percutaneous cryoablation as a salvage therapy for local recurrence of lung cancer

AU - Goto, Taichiro

AU - Izumi, Yotaro

AU - Nakatsuka, Seishi

AU - Nomori, Hiroaki

PY - 2012/8

Y1 - 2012/8

N2 - A 66-year-old male was diagnosed with inoperable non-small cell lung cancer, and underwent chemoradiotherapy, to which he achieved a partial response. During subsequent follow-up, positron emission tomography showed a fluorodeoxyglucose uptake lesion within the primary tumor, without evidence of metastatic foci elsewhere in the body. As local disease progression was most suspected, cryoablation was performed for the lesion with high fluorodeoxyglucose uptake. After treatment, there has been no evidence of recurrence for 12 months. Herein, we present a case of percutaneous cryoablation as a salvage therapy for recurrent lung cancer after chemoradiotherapy.

AB - A 66-year-old male was diagnosed with inoperable non-small cell lung cancer, and underwent chemoradiotherapy, to which he achieved a partial response. During subsequent follow-up, positron emission tomography showed a fluorodeoxyglucose uptake lesion within the primary tumor, without evidence of metastatic foci elsewhere in the body. As local disease progression was most suspected, cryoablation was performed for the lesion with high fluorodeoxyglucose uptake. After treatment, there has been no evidence of recurrence for 12 months. Herein, we present a case of percutaneous cryoablation as a salvage therapy for recurrent lung cancer after chemoradiotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84864219871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864219871&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2012.01.090

DO - 10.1016/j.athoracsur.2012.01.090

M3 - Article

C2 - 22579884

AN - SCOPUS:84864219871

VL - 94

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 2

ER -